AMPHASTAR FRANCE PHARMACEUTICALS
SIREN 801531427
No insolvency procedure
No collective procedure published in the BODACC window loaded by Solvenda. Monitoring continues daily.
Index between 75 and 84
Index entre 75 et 84 : objectifs de progression à définir et publier (art. L1142-9-1)
- Score published : 79/100 (edition 2025)
- Previous edition (2024) : 89/100
- Headcount band : 50 à 250
- Sector : Industrie manufacturière
- Department : Oise
Source: Gender Equality Index published by the French Ministry of Labour, Open Licence 2.0. Absence from an edition may also mean the company left the obligation.
1 agreement(s) filed, 1 with a term date
| Agreement | Theme | Term |
|---|---|---|
| Négociation Annuelles Obligatoires | Evolution des primes | 213 days (2027-03-31) |
Source: ACCO database of company agreements, DILA and Légifrance, Open Licence 2.0.
Solvenda watches for you, every morning.
Monitor this SIREN and your whole portfolio automatically.
Get started Risk index →Frequently asked questions
Is AMPHASTAR FRANCE PHARMACEUTICALS in insolvency proceedings?
No collective procedure is published in the BODACC for SIREN 801531427 in the window loaded by Solvenda. This is not a solvency guarantee; monitoring continues daily.
Does the absence of a BODACC procedure guarantee solvency?
No. It only proves no insolvency procedure is published to date. Continuous monitoring by SIREN remains necessary.
What is the gender equality index of AMPHASTAR FRANCE PHARMACEUTICALS?
AMPHASTAR FRANCE PHARMACEUTICALS published a score of 79 for the 2025 edition. Below 75, a company has three years to correct, failing which a penalty of up to 1% of payroll may apply.
Does AMPHASTAR FRANCE PHARMACEUTICALS have collective agreements?
1 company agreement(s) filed by AMPHASTAR FRANCE PHARMACEUTICALS appear in the public ACCO database, of which 1 reach their term within twelve months.